Genomic characterization of carbapenemase-producing Enterobacterales from wastewater reveals the convergence of KPC-2 and GES-16 in Brazil Authors: João Pedro Rueda Furlan, Giovanna Carrasco Bueno, Rubens Renato Sousa-Carmo, Renan Lourenço Oliveira Silva, Mikaela Renata Funada Barbosa, Maria Ines Zanoli Sato, Nilton Lincopan, Sergio Schenkman Published: 2026 ABSTRACT AbstractCarbapenemase-producing Enterobacterales (CPE) pose a significant public health concern due to the limited therapeutic options and increasing dissemination outside clinical settings. Wastewater treatment plants (WWTPs) have been proposed as relevant environmental reservoirs for antimicrobial-resistant bacteria and mobile genetic elements. In this study, we performed genomic characterization of CPE strains recovered from raw wastewater samples from the influents of different WWTPs. Antimicrobial susceptibility testing revealed multidrug resistance, including coresistance to carbapenems and polymyxins, among Klebsiella pneumoniae, Enterobacter asburiae, and Enterobacter kobei strains. Whole-genome sequencing identified the convergence of the blaKPC-2 and blaGES-16 genes, as well as the presence of blaGES-5 in E. kobei sequence type (ST) 540 strains. Moreover, the blaKPC-2 gene was detected in K. pneumoniae strains belonging to high-risk clones ST11 (capsular types KL64 and KL15) and ST307 (capsular type KL102), and E. asburiae ST384. The blaGES-5 and blaGES-16 genes were associated with class 1 integrons, while the blaKPC-2 gene was embedded within transposons (Tn4401a, Tn4401i, and Tn3-like) and insertion sequences (ISKpn27 and ISKpn6). Notably, genomic analyses and literature review demonstrated that the blaGES-16 gene remains unique to Brazil. The putative pathogenic potential of carbapenem-resistant K. pneumoniae ST11 was also assessed. These findings support the environmental circulation of clinically relevant Enterobacterales genotypes and emphasize the potential role of WWTPs as conduits for CPE dissemination, if not adequately operated. Therefore, genomic surveillance in extra-hospital settings may contribute to a better understanding of antimicrobial resistance ecology and inform One Health mitigation strategies.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1007/s10661-026-15867-0.Keywords: Antimicrobial resistance, Carbapenemase-producing Enterobacterales, Whole-genome sequencing, Mobile genetic elements, South America Introduction Carbapenem-resistant Enterobacterales (CRE) have emerged as critical threats to global public health due to their association with limited therapeutic options, high morbidity, and mortality (Gürbüz & Gencer, 2024). Accordingly, the World Health Organization has classified CRE among the critical priority pathogens (Sati et al., 2025). Among CRE, carbapenem-resistant Klebsiella pneumoniae has become one of the most prominent pathogens causing nosocomial infections worldwide, with K. pneumoniae accounting for a large proportion of carbapenem-resistant bloodstream and healthcare-associated bloodstream infections (BSIs) across multiple regions, representing 14.2% of CRE in Brazilian BSIs (Antochevis et al., 2025). In extra-hospital settings, wastewater treatment plants (WWTPs) are increasingly recognized as critical environmental reservoirs and routes for antimicrobial resistance (AMR) dissemination (La Rosa et al., 2025). Wastewater often contains a mixture of bacteria, xenogenetic pollutants, and selection compounds, creating favorable conditions for horizontal gene transfer and the persistence of antimicrobial-resistant species in the environmental sector (Karkman et al., 2018; Mutuku et al., 2022). Wastewater surveillance of AMR by genomic analysis offers a powerful approach to monitor critical priority pathogens. By analyzing wastewater, it becomes feasible to detect early signals of pathogen circulation, track the appearance of novel or regionally emerging species, clones, and antimicrobial resistance genes (ARGs), and observe unusual combinations of AMR and virulence traits (Sousa-Carmo & Lincopan, 2025). From a One Health perspective, the rapid dissemination of carbapenemase-producing Enterobacterales (CPE) is facilitated by the mobilization of carbapenemase genes via mobile genetic elements (MGEs), often coupled with clonal expansion (Ragheb et al., 2022). The role of MGEs in disseminating carbapenemase genes has been documented across South America, demonstrating how these elements drive intra- and interspecies transmission dynamics and exacerbate the AMR crisis (Reyes et al., 2020). Furthermore, the presence of class 1 integrons in WWTPs remains a reliable signal of AMR burden and dissemination potential (Tavares et al., 2024). Therefore, this study aimed to characterize CPE strains recovered from wastewater samples from WWTPs in Brazil and understand the genetic environments surrounding the carbapenemase genes. Materials and methods Sampling sites and bacterial obtaining Between April and May 2024, raw wastewater samples (500 mL) were collected from the influents of four WWTPs, denominated Ribeirão Preto (RP, 21°06′17.9″S 47°48′42.3″W), Riacho Grande (RG, 23°46′39.5″S 46°31′59.8″W), Parque Novo Mundo (PNM, 23°30′53.0″S 46°33′27.0″W), and Barueri (BA, 23°30′51.0″S 46°50′39.0″W), located in the state of São Paulo, Brazil. The samples were filtered using nitrocellulose membranes with 0.45-µm pore size (Merck Millipore Ltd., Ireland), and the membranes were added to test tubes with 5 mL of Brain Heart Infusion Broth (BHI, Kasvi, Spain), which were incubated at 37 ± 2 °C for 24 h. Then, 50 µL of each culture was seeded on plates of BBL™ CHROMagar™ Orientation plates (BD, France) with 4 mg/L of meropenem and vancomycin, and the plates were incubated at 37 ± 2 °C for 24 h. Finally, macroscopically different colonies were selected and identified using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Germany). For K. pneumoniae strains, the hypermucoviscous phenotype was evaluated by the Sting test (Shon et al., 2013). Antimicrobial susceptibility testing and phenotypic identification of carbapenemases The disk diffusion method was performed to determine the antimicrobial susceptibility to meropenem (MPM, 10 µg), imipenem (IPM, 10 µg), aztreonam (ATM, 30 µg), ceftazidime + avibactam (CZA, 30/20 µg), ceftazidime (CAZ, 30 µg), ceftriaxone (CRO, 30 µg), cefepime (CPM, 30 µg), cefoxitin (CFO, 30 µg), ampicillin + sulbactam (APS, 10/10 µg), amoxicillin + clavulanic acid (AMC, 20/10 µg), trimethoprim + sulfamethoxazole (SXT, 1.25/23.75 µg), ciprofloxacin (CIP, 5 µg), tetracycline (TET, 30 µg), minocycline (MIN, 30 µg), gentamicin (GEN, 10 µg), amikacin (AMI, 30 µg), chloramphenicol (CHL, 30 µg), and nitrofurantoin (NIT, 300 µg) (CECON, Brazil). Additionally, the broth microdilution method was used to determine the minimum inhibitory concentration (MIC) for MPM, colistin (COL), and tigecycline (TGC) (CLSI, M100™, 34th ed., 2024; EUCAST, v.14.0, 2024; EUCAST, 2006). Phenotypic carbapenemase production was assessed by inhibitor-based methods (Pournaras et al., 2010). Whole-genome sequencing and bioinformatic analyzes Genomic DNA was extracted using the PureLink™ Genomic DNA Mini Kit (Thermo Fisher Scientific, USA), and short-read sequencing was performed in the Illumina HiSeq platform (Illumina Inc., USA). The draft genome was de novo assembled by SPAdes v.3.15.2 (https://github.com/ablab/spades), and its quality was checked using CheckM v.1.1.6 (https://github.com/Ecogenomics/CheckM) (Supplementary Table S1). The bacterial identification at the species level was assessed by average nucleotide identity (ANI) and digital DNA-DNA hybridization (dDDH) analyses (Meier-Kolthoff et al., 2022; Richter et al., 2016). Resistome (acquired and intrinsic ARGs, point mutations, and biocide and metal tolerance genes), plasmid replicons, mobilome (transposons, integrons, and insertion sequences), virulome, and molecular typing (multilocus sequence typing and surface polysaccharide typing) were determined using tools available at the Center for Genomic Epidemiology (https://www.genomicepidemiology.org/), Microbial Ecology Group (https://www.meglab.org/), ISfinder (https://www-is.biotoul.fr/index.php), BLAST® (https://blast.ncbi.nlm.nih.gov/Blast.cgi), BIGSdb-Pasteur (https://bigsdb.pasteur.fr/), VFDB (https://www.mgc.ac.cn/VFs/), and Pathogenwatch (https://pathogen.watch/). For colistin-resistant K. pneumoniae strains, mutations in polymyxin resistance determinants were searched and analyzed as previously described by Furlan et al. (2023). Data availability The nucleotide sequences of all CPE strains used in this study are available in the NCBI database under the BioProject number PRJNA1216268. Results and discussion CRE and CPE strains Twelve CRE bacterial strains were isolated in the WTTPs studied. Species identification revealed Enterobacter asburiae (n = 1), Enterobacter kobei (n = 2), and K. pneumoniae (n = 9). Identification was supported by MALDI-TOF MS (score > 2.0), and it was confirmed genomically by ANI (> 95%) and dDDH (> 70%) (Table 1). All strains displayed multidrug resistance, with resistance to carbapenems, and harbored genes encoding serine carbapenemases. MIC values for meropenem were > 64 mg/L. Colistin MICs ranged from 1 to > 64 mg/L, with 75% (9/12) of strains classified as colistin-resistant (Table 1). In contrast, all strains were susceptible to CZA and TGC (MIC ≤ 2 mg/L). Phenotypic screening revealed carbapenemase activity in all strains, with phenylboronic acid inhibition suggesting serine carbapenemases (Supplementary Table S2). Consistently, the carbapenemase genes blaKPC-2, blaGES-5, and blaGES-16 were identified, with blaKPC-2 predominating (11/12; 91.6%). Notably, E. kobei strain M1 coharbored blaKPC-2 and blaGES-16 genes (Table 2). Table 1Isolation source, species, and AMR profiles of the bacterial strains used in this studyIsolation sourceaStrainSpeciesAMR profile (MIC mg/L)bRP-AM1E. kobeiCRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, GEN, AMI, NITRP-AM2K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, GEN, AMI, TET, MIN, CHL, SXT, NIT, COL (> 64)RP-AM5K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, GEN, MIN, SXT, NIT, COL (4)RG-AM9E. asburiaeCRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, AMI, MIN, NIT, COL (> 64)PNM-AM15K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, GEN, TET, MIN, SXT, NIT, COL (4)PNM-AM37E. kobeiCRO, CAZ, CPM, MPM (> 64), IPM, CIP, AMI, TET, MIN, CHL, FOS, COL (> 64)PNM-BM17K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, GEN, AMI, TET, MIN, CHL, SXT, NIT, COL (> 64)PNM-BM36K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, TET, MIN, CHL, SXT, NIT, COL (> 64)BA-AM30K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, GEN, AMI, TET, MIN, SXT, NITBA-AM33K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, GEN, AMI, TET, MIN, SXT, NITBA-BM32K. pneumoniaeCRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, TET, MIN, SXT, NIT, COL (8)BA-BM35K. pneumoniaeAMC, APS, CFO, CRO, CAZ, CPM, ATM, MPM (> 64), IPM, CIP, MIN, CHL, SXT, COL (> 64)aCollection date: RP-A and RG-A (04/17/2024); PNM-A (04/25/2024); BA-A (05/14/2024); PNM-B and BA-B (05/16/2024)bEnterobacter cloacae complex has intrinsic resistance to AMC, APS, and CFO tested Isolation source, species, and AMR profiles of the bacterial strains used in this study aCollection date: RP-A and RG-A (04/17/2024); PNM-A (04/25/2024); BA-A (05/14/2024); PNM-B and BA-B (05/16/2024) bEnterobacter cloacae complex has intrinsic resistance to AMC, APS, and CFO tested Table 2Genomic characteristics of CPE strains from this studyStrainTypingdAntimicrobial resistance geneeVirulence determinantfPlasmid repliconSTSerotypingM1a520nablaKPC-2, blaGES-16, blaTLA-like, blaACT-102, aac(6′)-Ib3, tet(C), msr(E), mph(E)ndIncFIB(K), IncP6, Col(pHAD28), Col(IRGK)M2b11O1/O2v1:KL64blaKPC-2, blaCTX-M-2, blaOXA-2, blaTEM-1B, blaSHV-11, oqxA, oqxB, rmtB, aac(3)-IId, aac(6′)-Ib3, aph(3″)-Ib, aph(6)-Id, tet(G), sul1, sul2, catA1, mph(A), erm(42), fosAKPmrk gene cluster, ICEKp10, clb 3IncFII(K), IncFIB(pQil), IncFIB(K), ColRNAIM5b307O1/O2v2:KL102blaKPC-2, blaCTX-M-15, blaOXA-1, blaTEM-1B, blaSHV-28, qnrB1, oqxA, oqxB, aac(6′)-Ib-cr, aph(3″)-Ib, aph(6)-Id, aac(3)-IIa, sul2, dfrA14, catB3, mph(A), fosAKPmrk gene clusterIncFII(K), IncFIB(K), IncC3M9c384nablaKPC-2, blaOXA-9, blaACT-34, blaTEM-1A, aac(6′)-Ib, aph(3′)-VIa, aadA1fimA, fimC, fimD, fimI, fimZ, fepA, entB, entE, entSIncFII(Yp), IncFII(SARC14), IncFIA(HI1), IncFIB(K)M15b307O1/O2v2:KL102blaKPC-2, blaCTX-M-15, blaOXA-1, blaTEM-1B, blaSHV-28, qnrB1, oqxA, oqxB, aac(6′)-Ib-cr, aac(3)-IIa, aph(6)-Id, aph(3″)-Ib, catB3, sul2, dfrA14, mph(A), fosAKPmrk gene clusterIncFII(K), IncFIB(K), IncC3M37a520nablaGES-5, blaOXA-10, blaACT-102, qnrVC4, aph(3′)-VIa, aac(6′)-Ib3, aadA1, cmlA5, dfrA14, msr(E), mph(E), fosAKPndIncFIB(K), IncQ1, IncP6M17b307O1/O2v2:KL102blaKPC-2, blaCTX-M-15, blaOXA-1, blaTEM-1B, blaSHV-28, qnrB1, oqxA, oqxB, aac(6′)-Ib-cr, aac(3)-IIa, aph(6)-Id, aph(3″)-Ib, sul2, dfrA14, catB3, mph(A), fosAKPmrk gene clusterIncFII(K), IncFIB(K), IncC3M36b11O1/O2v1:KL64blaKPC-2, blaSHV-11, aac(6′)-Ib3, oqxA, oqxB, tet(A), sul1, sul2, dfrA30, mph(A), fosAKPmrk gene cluster, ICEKp10, clb 3IncFIB(K), IncFIB(K), IncFIB(pQil), IncN, ColRNAI, Col440llM30b11O4:KL15blaKPC-2, blaCTX-M-15, blaLAP-2, blaOXA-9, blaOXA-1, blaTEM-1A, blaSHV-11, aph(3′)-Ia, qnrS1, oqxA, oqxB, aac(6′)-Ib-cr, aac(3)-IIa, aadA2, tet(A), sul1, sul2, dfrA12, catB3, mph(A), fosAKPmrk gene cluster, ICEKp3IncFII(K), IncFIB(K), IncFIB(pQil), IncC, IncN-pST15, ColRNAl, Col440lM33b11O1/O2v1:KL64blaKPC-2, blaCTX-M-2, blaOXA-2, blaTEM-1B, blaSHV-11, oqxA, oqxB, rmtB, aac(3)-IIa, aac(6′)-Ib3, aph(6)-Id, aph(3″)-Ib, tet(G), sul1, sul2, catA1, erm(42), mph(A), fosAKPmrk gene cluster, ICEKp10, clb 3IncFII(K), IncFIB(K), IncFIB(pQil), ColRNAIM32b11O4:KL15blaKPC-2, blaCTX-M-15, blaLAP-2, blaOXA-9, blaOXA-1, blaTEM-1A, blaSHV-11, aph(3′)-Ia, qnrS1, oqxA, oqxB, aac(6′)-Ib-cr, aac(3)-IIa, aadA2, tet(A), sul1, sul2, dfrA12, catB3, mph(A), fosAKPmrk gene cluster, ICEKp3IncFII(K), IncFIB(K), IncFIB(pQil), IncC, IncN-pST15, ColRNAl, Col440lM35b307O1/O2v2:KL102blaKPC-2, blaCTX-M-15, blaOXA-1, blaTEM-1B, blaSHV-28, qnrB1, oqxA, oqxB, aac(6′)-Ib-cr, aac(3)-IIa, aph(3″)-Ib, aph(6)-Id, sul2, dfrA14, mph(A), fosAKPmrk gene clusterIncFII(K), IncFIB(K), IncC3aE. kobeibK. pneumoniaecE. asburiaedST sequence type, na not appliedeTruncated ARGs were not listedfnd not detected Genomic characteristics of CPE strains from this study aE. kobei bK. pneumoniae cE. asburiae dST sequence type, na not applied eTruncated ARGs were not listed fnd not detected The environmental spread of CRE and CPE, particularly through inadequately treated wastewater discharged from WWTPs, is a key factor driving AMR within the One Health perspective (Larsson & Flach, 2022). In Brazil, CPE strains have been reported in wastewater samples from WWTP effluents (Montenegro et al., 2023). Recently, Citrobacter freundii sequence type (ST) 522 and K. pneumoniae ST258 strains were detected as harboring novel blaKPC-2 allelic variants in the PNM site (Furlan et al., 2025a), while unusual species such as Comamonas resistens carrying the blaGES-5 gene (Furlan et al., 2025b) and Serratia nevei harboring the blaNDM-1 gene were identified in the RG site (Furlan et al., 2025c). These findings reinforce the role of WWTPs as environmental reservoirs and mixing points for clinically relevant AMR determinants, high-risk lineages, and unusual species (La Rosa et al., 2025). High-risk and international clones encompassing a wide range of genomic traits K. pneumoniae strains belonged to recognized high-risk clones, namely, ST11 and ST307 (Table 2). ST11 was recovered on different WWTPs and collection dates, indicating a nonsporadic presence and multipoint environmental input, rather than a single isolated contamination event. In addition, the occurrence of two distinct capsular (KL) types (KL64 and KL15) within ST11 showed capsular diversity, a feature that may reflect ecological plasticity and the contribution of different source populations to the sewage network (Chen et al., 2023; Zhou et al., 2020). For ST307, although only one capsular type (KL102) was observed, its detection in more than one WWTP also supports the hypothesis of multiple introduction routes, consistent with this clone’s strong healthcare association and its ability to spread through urban wastewater systems (Peirano et al., 2020; Wyres et al., 2019). These high-risk clones are globally successful in causing healthcare-associated infections and frequently harbor carbapenemase genes, with ST11-KL64 typically linked to highly transmissible, virulent, and carbapenemase-producing sublineages, whereas ST11-KL15 has been associated with more heterogeneous epidemiological backgrounds, often reflecting broader environmental or community dissemination (Chen et al., 2025; Shi et al., 2024; Wang et al., 2023). E. kobei strains belonged to international clone ST520. This clone has been previously reported as carbapenem-resistant and recovered from coastal waters from Brazil (Sellera et al., 2017) and clinical samples from China, India, and Spain (Halder et al., 2025; Peirano et al., 2018; Wang et al., 2017; Zhao et al., 2020), showing its occurrence across geographically distant regions. Conversely, the E. asburiae strain M9 belonged to ST384, for which no previous reports were found, indicating that this lineage may be rare or undercharacterized. Although its epidemiological relevance remains unclear, the detection of ST384 in wastewater underscores how environmental genomic surveillance can reveal previously unreported Enterobacter species diversity. In addition to serine carbapenemase genes, all strains harbored acquired and intrinsic genes mainly related to resistance to β-lactams, fluoroquinolones, aminoglycosides, tetracyclines, sulfonamides, and phenicols (Table 2). Accordingly, genes encoding extended-spectrum β-lactamases (blaCTX-M-2 and blaCTX-M-15) and a 16S rRNA methyltransferase (rmtB) stand out, since they confer resistance to clinically important antimicrobials, such as third-generation cephalosporins (e.g., ceftriaxone) and aminoglycosides (e.g., amikacin), respectively. All fluoroquinolone-resistant K. pneumoniae strains presented mutations in the quinolone resistance-determining regions of GyrA (S83I) and ParC (S80I) (Supplementary Table S3), whereas multiple mutations were detected in polymyxin resistance determinants among colistin-resistant K. pneumoniae strains, including the disruption of mgrB by an ISKpn14 element and a deleterious R256G substitution in PmrB (Supplementary Table S4). These results corroborate the phenotype-genotype concordance widely reported in Enterobacterales, where the presence of known ARGs, point mutations, and insertion/disruption events detected by genomics generally predicts the AMR phenotypes observed in susceptibility testing (Li et al., 2024; Vanstokstraeten et al., 2023). Moreover, genes associated with tolerance to biocides (quaternary ammonium compounds) and metals (arsenic, copper, mercury, and silver) were also identified (Supplementary Table S5). The putative pathogenic potential of K. pneumoniae and Enterobacter spp. was assessed based on virulence determinants. All K. pneumoniae strains carried the mrk gene cluster encoding type 3 fimbriae, which are associated with adhesion, colonization, and biofilm formation (Liu et al., 2024). Additionally, the yersiniabactin siderophore locus embedded in integrative conjugative elements ICEKp was detected, corresponding to ICEKp3 and ICEKp10 variants in ST11-KL15 and ST11-KL64 strains, respectively. This virulence mechanism facilitates iron acquisition, immune evasion, and oxidative stress resistance, contributing to increased pathogenicity (Tan et al., 2024). Notably, the ST11-KL64 strain also harbored the colibactin gene cluster, specifically the clb 3 variant, which encodes a genotoxin linked to DNA damage, epithelial barrier disruption, and persistence during infection (Lan et al., 2019). K. pneumoniae ST307-KL102 strains presented the hypermucoviscosity phenotype, demonstrating increased capsule production that enhances resistance to host immune responses (Heiden et al., 2020). Conversely, the virulence determinants of Enterobacter species remain rather unclear (Davin-Regli et al., 2019). E. asburiae strain M9 carried determinants associated with adhesion (fim genes) and iron acquisition (fepA, entB, entE, and entS) (Table 2), which are characteristic of opportunistic Enterobacterales and support host colonization rather than hypervirulence (Amaretti et al., 2020; Azam et al., 2023). In E. kobei, no classical or experimentally validated virulence determinants were detected (Table 2). This pattern is consistent with the opportunistic lifestyle of Enterobacter species, in which pathogenicity largely depends on basic fitness traits and host susceptibility, rather than on specialized virulence systems typical of hypervirulent Enterobacterales. In contrast, the detection of putative hypervirulent, hypermucoviscous, and carbapenem-resistant K. pneumoniae in WWTPs is particularly concerning, as it demonstrates the environmental circulation of high-risk clones harboring ARGs and virulence-associated features. The isolated CPE strains also carried several plasmid replicons, particularly IncF-type, which are well recognized for disseminating AMR and virulence determinants among Enterobacterales (Rozwandowicz et al., 2018). Furthermore, IncN-pST15 and IncP6 plasmid replicons were also identified. These plasmids have been described as carrying the blaKPC-2 gene in K. pneumoniae and Escherichia coli strains from surface water and agricultural soil in southeastern Brazil (Furlan et al., 2023, 2024), reinforcing the regional environmental dissemination of carbapenemase genes. However, due to methodological constraints associated with short-read sequencing, it was not possible to fully resolve and assemble these plasmids into complete contigs, preventing a more detailed reconstruction of their genomic architecture and cargo (Arredondo-Alonso et al., 2017). Genetic contexts of serine carbapenemase genes All K. pneumoniae strains, except the M36 strain, carried the blaKPC-2 gene embedded within the Tn4401a transposon (Fig. 1A). Conversely, the blaKPC-2 gene from the M36 strain was located within the Tn4401i isoform (Fig. 1B). Classical transposons, such as Tn4401, have been central to the global dissemination of blaKPC-2, particularly among hospital-associated K. pneumoniae lineages, but structural variability within Tn4401 isoforms, especially Tn4401a, has been increasingly documented and linked to differences in mobility and epidemiological impacts (Naas et al., 2008; Reyes et al., 2020). Curiously, the uncommon Tn4401i isoform was reported in high-risk clones of K. pneumoniae ST11 and ST258 from clinical and environmental sectors of Brazil (Araújo et al., 2018; Rosa et al., 2024), but its epidemiological risk remains unclear, highlighting the need for continued surveillance. Schematic representation of the genetic contexts harboring genes encoding serine carbapenemases in the indicated isolates. A The blaKPC-2 gene is embedded in the Tn4401a transposon (GenBank: KT378596). B The blaKPC-2 gene embedded in the Tn4401i transposon (GenBank: MH047294). C The blaKPC-2 gene is associated with ISKpn27 and ISKpn6. D The blaKPC-2 gene is associated with ISKpn6. E Fragment harboring the blaGES-5 gene associated with class 1 integron integrase gene intI1 and In1300 integron (GenBank: CP022170). F The blaGES-16 gene is associated with the class 1 integron integrase gene intI1. Genes encoding serine carbapenemases are highlighted in bold. Hypothetical protein, hp In E. kobei strain M1 and E. asburiae strain M9, the blaKPC-2 gene was inserted into ISKpn27-ΔblaTEM-blaKPC-2-ΔISKpn6 (Fig. 1C) and tnpA-blaKPC-2-ΔISKpn6 (Fig. 1D) genetic structures, respectively. These platforms also carried tnpA genes related to the Tn3-family transposon. Genetic contexts involving Tn3-associated transposases indicate that nonclassical mobilization routes, which may facilitate carbapenemase capture and transfer across diverse hosts, reflect the plasticity of resistance loci (Casacuberta & González, 2013; Partridge et al., 2018). Accordingly, these genetic platforms could represent early stages of mobilization pathways before stabilization in clinically dominant vehicles, underscoring their potential role in shaping emerging resistance dynamics. The blaGES-5 (Fig. 1E) and blaGES-16 (Fig. 1F) genes identified in E. kobei strains M1 and M37 were surrounded by the class 1 integron integrase gene intI1 with attI and attC regions. Furthermore, the In1300 integron was identified in the same fragment of the blaGES-5 gene (Fig. 1E). The association of blaGES allelic variants with class 1 integrons highlights a highly efficient mechanism of genetic mobilization, as these evolutionary platforms can capture, excise, and rearrange gene cassettes through the intI1 integrase, thereby promoting the accumulation and transfer of clinically relevant ARGs (Gillings, 2014). Therefore, these MGE-mediated recruitments and spread are particularly concerning in anthropogenically impacted environments, ultimately bridging the clinical-environmental interface and enhancing the adaptive potential of the resistome (Gillings, 2017; Khedkar et al., 2022). Genomic context of the blaGES-16 gene GES-16 carbapenemase, encoded by the blaGES-16 gene, differs from the GES-5 carbapenemase by a single amino acid substitution (Gln38Glu). This carbapenemase was first described in clinical strains of Serratia marcescens from Rio de Janeiro, Brazil (Streling et al., 2018). Subsequently, blaGES-16 was also detected in Aeromonas veronii strains from hospital wastewater in Paraná (Conte et al., 2021, 2022). By using the NCBI’s genome resources on January 7, 2026, only five public genomes carrying blaGES-16 were identified, all originating from Brazil (Fig. 2), indicating that its known distribution remains geographically restricted. This gene was observed in clinical and environmental strains of Aeromonas hydrophila (ST508), A. veronii (ST886), Enterobacter kobei (ST32), Enterobacter soli, and Pseudomonas aeruginosa (ST3603) isolated from different Brazilian states (Fig. 2). Accordingly, the distribution of the blaGES-16 gene remains geographically restricted to Brazil. Additionally, GES-16-positive FL126, BT722, and Aer_101 genomes also carried the KPC-2 carbapenemase. Schematic representation of integron-related sequences containing the blaGES-16 gene in Brazilian genomes. The blaGES-16 gene is highlighted in bold. Hypothetical protein, hp In the genomes studied, the blaGES-16 gene was identified on chromosome and plasmid contigs, which were inferred from nucleotide BLAST alignment. It was consistently associated with the class 1 integron integrase gene intI1, highlighting the role of the class 1 integrons in the maintenance of this gene. Moreover, ARGs, including the blaOXA-17 gene that encodes an extended-spectrum β-lactamase and insertion sequences, were also found surrounding the blaGES-16 gene (Figs. 1F and 2). These results indicate that blaGES-16 is embedded in distinct integron-associated structures, consistent with the well-established role of class 1 integrons as platforms that capture, rearrange, and disseminate blaGES allelic variants across bacterial hosts and ecological niches (Tavares et al., 2025). Conclusions In summary, this study provides genomic evidence that WWTPs serve as key environments for AMR evolution, acting as environmental reservoirs and dissemination pathways, when treatment is inadequate, for CPE strains and MGEs linked to the spread of carbapenemase genes. The detection of these bacteria and genetic elements outside clinical settings underscores the ecological connectivity between human-associated pathogens and the environment, while also highlighting raw wastewater as an early warning signal of the circulation of high-risk lineages within the human population. Thus, the diversity of genetic platforms associated with serine carbapenemase genes in Enterobacterales from WWTPs highlights the dynamic nature of MGEs in driving AMR dissemination. Therefore, continuous genomic surveillance in extra-hospital compartments is essential to monitor emerging AMR genotypes and detect early signs of clinically relevant dissemination. Supplementary Information Below is the link to the electronic supplementary material. (DOCX 42.9 KB) Acknowledgements The authors thank the São Paulo Research Foundation (FAPESP) and the National Council for Scientific and Technological Development (CNPq) for fellowships. Author contributions João Pedro Rueda Furlan: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing – original draft, Writing – review & editing. Giovanna Carrasco Bueno: Investigation, Methodology, Writing – review & editing. Rubens Renato Sousa-Carmo: Investigation, Methodology, Writing – review & editing. Renan Lourenço Oliveira Silva: Investigation, Methodology, Writing – review & editing. Mikaela Renata Funada Barbosa: Investigation, Methodology, Writing – review & editing. Maria Ines Zanoli Sato: Investigation, Methodology, Writing – review & editing. Nilton Lincopan: Conceptualization, Funding acquisition, Investigation, Project administration, Supervision, Writing – review & editing. Sergio Schenkman: Conceptualization, Funding acquisition, Investigation, Project administration, Supervision, Writing – review & editing. Funding The Article Processing Charge (APC) for the publication of this research was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) (ROR identifier: 00x0ma614). This study was supported by FAPESP (grant numbers 21/10599-3, 23/16216-4. 24/05243-3, and 24/06593-8) and CNPq (grant numbers 303788/2020-8 and 314336/2021-4). Data availability The nucleotide sequences of all CPE strains used in this study are available in the NCBI database under the BioProject number PRJNA1216268. Declarations Ethics approval Not required. Consent to participate Not applicable. Consent for publication Not applicable. Ethical responsibilities of authors All authors have read, understood, and complied as applicable with the statement on “ethical responsibilities of authors.” Competing interests The authors declare no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information João Pedro Rueda Furlan, Email: joao.furlan@academico.ufpb.br. Sergio Schenkman, Email: sschenkman@unifesp.br. References Associated Data Supplementary Materials (DOCX 42.9 KB) Data Availability Statement The nucleotide sequences of all CPE strains used in this study are available in the NCBI database under the BioProject number PRJNA1216268. The nucleotide sequences of all CPE strains used in this study are available in the NCBI database under the BioProject number PRJNA1216268.